Institutional investors purchased a net $1.4 million shares of ASMB during the quarter ended June 2017. This may signal that the smart money is gaining interest in this company as the 77.08% of the shares outstanding that institutional investors hold is among the lowest in the Pharmaceuticals: Other industry.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
BLACKROCK FUND ADVISORS Bought 496.5 Thousand shares of Assembly Biosciences Inc
NORTHERN TRUST INVESTMENTS, INC. Bought 134.5 Thousand shares of Assembly Biosciences Inc